123Genetix
123Genetix is a biotechnology company focused on revolutionizing stem cell research and drug discovery, particularly for rare diseases. Their core offering is the DeepNEU platform, a big data simulation solution that utilizes AI, machine learning, and advanced logic to create simulated stem cell models. This platform empowers researchers by enabling them to develop new disease hypotheses, design experimental simulations, write better research grants, and identify potential biomarkers for drug discovery. They aim to reduce the high costs and inefficiencies of traditional wet-lab research. 123Genetix offers access to simulations, custom simulation design, and shares in drug development revenue as their business model. They have completed 17 rare disease simulations and are initiating research programs with key opinion leaders, positioning themselves as a key player in the growing stem cell and rare disease research market.
123Genetix
123Genetix is a biotechnology company focused on revolutionizing stem cell research and drug discovery, particularly for rare diseases. Their core offering is the DeepNEU platform, a big data simulation solution that utilizes AI, machine learning, and advanced logic to create simulated stem cell models. This platform empowers researchers by enabling them to develop new disease hypotheses, design experimental simulations, write better research grants, and identify potential biomarkers for drug discovery. They aim to reduce the high costs and inefficiencies of traditional wet-lab research. 123Genetix offers access to simulations, custom simulation design, and shares in drug development revenue as their business model. They have completed 17 rare disease simulations and are initiating research programs with key opinion leaders, positioning themselves as a key player in the growing stem cell and rare disease research market.